abstract |
The present invention relates to an imidazopyridine derivative as represented by general formula (I) or a pharmaceutically acceptable salt thereof, a preparation method therefor, and an application thereof as a therapeutic agent, in particular, as an IRAK4 kinase inhibitor, wherein the definitions of R 1, R 2, R 3, and R 4 in the general formula (I) are the same as those in the description. |